Fingolimod (FTY720) v. Placebo in Patients w/Relapsing MS

ID Number 06-0920

Principal Investigator(s)
Aaron Miller

Department(s) or Division(s)
Neurology

Description
The main purpose of this study is to evaluate how effective fingolimod is in reducing the number of relapses and in delaying disability progression in patients with relapsing-remitting MS.

Contact Information
Yadira Bencosme
(212) 241-5329
yadira.bencosme


Recruiting Patients: No